Ayabudge LLC - 17 Aug 2023 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
21 Aug 2023, 18:07:15 UTC
Prior SEC filing
16 Jun 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ayabudge LLC by Dale A. Sander as Attorney-in-Fact

Key filing fact

Ayabudge LLC filed Form 4 for Humacyte, Inc. (HUMA) on 21 Aug 2023.

Key facts

  • This page summarizes Ayabudge LLC's Form 4 filing for Humacyte, Inc. (HUMA).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 21 Aug 2023, 18:07.

Change

  • Previous filing in this sequence was filed on 16 Jun 2023.
  • Current net transaction value: -$6,378,837.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HUMA transaction

Common Stock

Sale

Transaction value
$2,098,240
Shares
-570,174
Change %
-5.7%
Price
$3.68
Shares after
9,420,562
Date
17 Aug 2023
Ownership
Direct
Footnotes
F1, F2
HUMA transaction

Common Stock

Sale

Transaction value
$2,238,315
Shares
-626,979
Change %
-6.7%
Price
$3.57
Shares after
8,793,583
Date
18 Aug 2023
Ownership
Direct
Footnotes
F1, F3
HUMA transaction

Common Stock

Sale

Transaction value
$2,042,282
Shares
-602,443
Change %
-6.9%
Price
$3.39
Shares after
8,191,140
Date
21 Aug 2023
Ownership
Direct
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Ayabudge LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 4 footnotes

Footnote F1

Between August 17, 2023 and August 21, 2023, the Reporting Person sold 1,799,596 shares of Common Stock. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for investors to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase.

Footnote F2

The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.50 to $4.13. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.50 to $3.75. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.22 to $3.80. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .